Ozanimod Therapy in a Patient With Ulcerative Colitis and Multiple Sclerosis: Hitting 2 Birds With 1 Stone

Simultaneous occurrence of multiple sclerosis (MS) and ulcerative colitis (UC) is seldom encountered by clinicians and poses unique challenges. The sphingosine-1-phosphate receptor modulator ozanimod has been recently approved for UC. Ozanimod can be used in such scenarios where it can treat both co...

Descripción completa

Detalles Bibliográficos
Autores principales: Vuyyuru, Sudheer K., Morrow, Sarah A., Jairath, Vipul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857283/
https://www.ncbi.nlm.nih.gov/pubmed/36699181
http://dx.doi.org/10.14309/crj.0000000000000955
_version_ 1784873832735047680
author Vuyyuru, Sudheer K.
Morrow, Sarah A.
Jairath, Vipul
author_facet Vuyyuru, Sudheer K.
Morrow, Sarah A.
Jairath, Vipul
author_sort Vuyyuru, Sudheer K.
collection PubMed
description Simultaneous occurrence of multiple sclerosis (MS) and ulcerative colitis (UC) is seldom encountered by clinicians and poses unique challenges. The sphingosine-1-phosphate receptor modulator ozanimod has been recently approved for UC. Ozanimod can be used in such scenarios where it can treat both conditions, reducing the need for multiple targeted therapies. We report the first case of successfully treated multiple sclerosis and UC with ozanimod.
format Online
Article
Text
id pubmed-9857283
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Wolters Kluwer
record_format MEDLINE/PubMed
spelling pubmed-98572832023-01-24 Ozanimod Therapy in a Patient With Ulcerative Colitis and Multiple Sclerosis: Hitting 2 Birds With 1 Stone Vuyyuru, Sudheer K. Morrow, Sarah A. Jairath, Vipul ACG Case Rep J Case Report Simultaneous occurrence of multiple sclerosis (MS) and ulcerative colitis (UC) is seldom encountered by clinicians and poses unique challenges. The sphingosine-1-phosphate receptor modulator ozanimod has been recently approved for UC. Ozanimod can be used in such scenarios where it can treat both conditions, reducing the need for multiple targeted therapies. We report the first case of successfully treated multiple sclerosis and UC with ozanimod. Wolters Kluwer 2023-01-20 /pmc/articles/PMC9857283/ /pubmed/36699181 http://dx.doi.org/10.14309/crj.0000000000000955 Text en © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Case Report
Vuyyuru, Sudheer K.
Morrow, Sarah A.
Jairath, Vipul
Ozanimod Therapy in a Patient With Ulcerative Colitis and Multiple Sclerosis: Hitting 2 Birds With 1 Stone
title Ozanimod Therapy in a Patient With Ulcerative Colitis and Multiple Sclerosis: Hitting 2 Birds With 1 Stone
title_full Ozanimod Therapy in a Patient With Ulcerative Colitis and Multiple Sclerosis: Hitting 2 Birds With 1 Stone
title_fullStr Ozanimod Therapy in a Patient With Ulcerative Colitis and Multiple Sclerosis: Hitting 2 Birds With 1 Stone
title_full_unstemmed Ozanimod Therapy in a Patient With Ulcerative Colitis and Multiple Sclerosis: Hitting 2 Birds With 1 Stone
title_short Ozanimod Therapy in a Patient With Ulcerative Colitis and Multiple Sclerosis: Hitting 2 Birds With 1 Stone
title_sort ozanimod therapy in a patient with ulcerative colitis and multiple sclerosis: hitting 2 birds with 1 stone
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857283/
https://www.ncbi.nlm.nih.gov/pubmed/36699181
http://dx.doi.org/10.14309/crj.0000000000000955
work_keys_str_mv AT vuyyurusudheerk ozanimodtherapyinapatientwithulcerativecolitisandmultiplesclerosishitting2birdswith1stone
AT morrowsaraha ozanimodtherapyinapatientwithulcerativecolitisandmultiplesclerosishitting2birdswith1stone
AT jairathvipul ozanimodtherapyinapatientwithulcerativecolitisandmultiplesclerosishitting2birdswith1stone

Ejemplares similares